342 related articles for article (PubMed ID: 26338721)
1. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus and the risk of cancer.
Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
[TBL] [Abstract][Full Text] [Related]
3. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.
Singh MK; Das BK; Choudhary S; Gupta D; Patil UK
Biomed Pharmacother; 2018 Oct; 106():991-1002. PubMed ID: 30119271
[TBL] [Abstract][Full Text] [Related]
5. Linking type 2 diabetes and gynecological cancer: an introductory overview.
Anastasi E; Filardi T; Tartaglione S; Lenzi A; Angeloni A; Morano S
Clin Chem Lab Med; 2018 Aug; 56(9):1413-1425. PubMed ID: 29427549
[TBL] [Abstract][Full Text] [Related]
6. [New clinical data with metformin therapy in patients with diabetes mellitus].
Jermendy G
Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
[TBL] [Abstract][Full Text] [Related]
7. Long-acting insulin analogs and cancer.
Sciacca L; Vella V; Frittitta L; Tumminia A; Manzella L; Squatrito S; Belfiore A; Vigneri R
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):436-443. PubMed ID: 29609864
[TBL] [Abstract][Full Text] [Related]
8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
9. Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study.
Buchs AE; Silverman BG
Metabolism; 2011 Oct; 60(10):1379-85. PubMed ID: 21696791
[TBL] [Abstract][Full Text] [Related]
10. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
11. Diabetes and cancer.
Chowdhury TA
QJM; 2010 Dec; 103(12):905-15. PubMed ID: 20739356
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis.
Karimi F; Dinarvand N; Sabaghan M; Azadbakht O; Ataee S; Kharazinejad E; Moazamfard M
Endocrine; 2024 Jan; 83(1):1-9. PubMed ID: 37552417
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and Cancer: a Review of Current Knowledge.
Wojciechowska J; Krajewski W; Bolanowski M; Kręcicki T; Zatoński T
Exp Clin Endocrinol Diabetes; 2016 May; 124(5):263-75. PubMed ID: 27219686
[TBL] [Abstract][Full Text] [Related]
14. [Diabetes and cancer: an injurious association].
Gariani K; Tran C; Philippe J
Rev Med Suisse; 2010 Jun; 6(252):1193-4, 1196-8. PubMed ID: 20614754
[TBL] [Abstract][Full Text] [Related]
15. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
17. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
Gallagher EJ; LeRoith D
Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
[TBL] [Abstract][Full Text] [Related]
18. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
[TBL] [Abstract][Full Text] [Related]
19. Perspectives of metformin use in endometrial cancer and other gynaecological malignancies.
Barczyński B; Frąszczak K; Kotarski J
J Drug Target; 2022 Apr; 30(4):359-367. PubMed ID: 34753372
[TBL] [Abstract][Full Text] [Related]
20. The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses.
Wen Q; Zhao Z; Wen J; Zhou J; Wu J; Lei S; Miao Y
Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():33-41. PubMed ID: 31009857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
